Delivery Order SPE2DB24D2011-SPE2DB25FBRNN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,183.60 to AmerisourceBergen Drug Corp for Lyrica 100 mg capsules (90-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lyrica 100 mg capsules (90 count) with a contract value of $4,272.77. This is a firm fixed price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competitive set-aside award. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lyrica 50 mg capsules (90-count units) at a ceiling value of $1,182.32. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a delivery order, with an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lyrica 100 mg capsules (90-count units) with a ceiling value of $8,137.10. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, is scheduled for completion by August 18, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lyrica 100 mg capsules (90-count) with a ceiling value of $1,213.60. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a competitively awarded, non-set-aside contract. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Lyrica 50 mg capsules (90-count units) under a firm fixed-price contract valued at $2,689.94. This is a non-set-aside competitive award with an ultimate completion date of August 4, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a $2,336.03 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Lyrica 100 mg capsules (90-count units). This competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,776.07 to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) on August 15, 2025, with completion scheduled for August 18, 2025. This firm fixed price, competitively awarded delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $1,810.77 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lyrica 75 mg capsules in unit dose packaging (100 units). This is a firm fixed price contract with an ultimate completion date of July 29, 2025, and represents a non-competitive set-aside award. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lyrica 100 mg capsules (90-count units) with a contract value of $3,157.69. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by September 16, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRNNDelivery Order
The Defense Logistics Agency awarded a $1,182.32 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lyrica 50 mg capsules (90-count). This competitively awarded, non-set-aside contract operates under a firm fixed price structure with an ultimate completion date of August 13, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, fulfills critical federal medical procurement needs for military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard, through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/12/25 |